Cited by 731Pancreatic function and diabetesDiabetes Treatment and ManagementRegulation of Appetite and Obesity

The incretin concept today

Open access
Creutzfeldt, W.·1979·Diabetologia

Abstract

1. The insulinogenic factor of the gastrointestinal mucosa named "incretin" is only one part of the complex enteroinsular axis. --2. Of the chemically defined gastrointestinal hormones GIP is the strongest incretin candidate. --3. Because of the dual function of GIP as gastrone and insulinotropic substance several safeguards against GIP-mediated insulin hypoglycaemia exist. --4. No pathological condition has yet been found which is causally related to hyper- or hyposecretion of GIP. However, an exaggerated GIP response (usually secondary to the disease) may participate in the pathogenesis of hyperinsulinaemia of patients with obesity and duodenal ulcer. --5. The injection of GIP antibodies only partially abolishes the incretin effect. Therefore, GIP, although important, is not the only incretin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf01225454

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 14

  1. Bloom, S.R.(ed.): Gut hormones. Edinburgh: Churchill Livingstone 1978
  2. Bajaj, J.S. (Ed.), pp. 76-82. Amsterdam: Excerpta Medica Intern. Congr. Ser. 413, 1977
  3. Moody, A. J., Sundby, F., Jacobsen, H., Lauritsen, K. B.: The tissue distribution and plasma levels of glicentin (gut GLI-I). Scand. J. Gastroenterol. [Suppl. 49] 13, 127 (1978)
  4. Andersen, D. K., Elahi, D., Brown, J. C., Debas, H. T., Tobin, J.D., Andres, R.: Insulin and glucagon responses to infusion of gastric inhibitory polypeptide (GI1 a) in man during control- led glycemia. Scand. J. Gastroenterol. [Suppl. 49] 13, 7 (1978)
  5. Arnold, R., Ebert, R., Creutzfeldt, W., Becker, H. D., B6rger, H.: Inhibition of gastric acid secretion by gastric inhibitory polypeptide (GIP) in man. Scand. J. Gastroenterol. [Suppl. 49] 13, 11 (1978)
  6. Brown, J. C., Pedersen, R. A.: GI hormones and insulin secre- tion. In: Endocrinology. Proceedings of the Vth Intemational Congress of Endocrinology, Vol. 2, pp. 568-570. Amsterdam: Excerpta Medica 1977
  7. Finke, U., Ebert, R., Creutzfeldt, W.: Different forms of immunoreactive gastric inhibitory polypeptide (IR-GIP) in human serum and intestinal mucosa. Diabetologa 15, 232 (1978)
  8. Bajaj, J. S. (Ed.), pp. 63-75. Amsterdam: Excerpta Medica Intern. Cong. Ser. 413, 1977
  9. Ebert, R., Creutzfeldt, W.: Aspect of GIP pathology. In: Gut hormones. Bloom, S.R. (Ed.), pp. 294-300. Edinburgh: Churchill Livingstone 1978
  10. Ebert, R., Creutzfeldt, W., Talaulicar, M., Wilims, B.: Inhibi- tion of fat, but not glucose induced release of gastric inhibitory polypeptide (GIP) by insulin or glucose. Diabetologia 15, 229 (1978)
  11. Bloom, S. R.: GIP in diabetes. Diabetologia 11, 334 (1975)
  12. Ebert, R., Frerichs, H., Creutzfeldt, W.: Serum gastric inhibi- tory polypeptide (GIP) response in patients with maturity onset diabetes and in juvenile diabetics. Diabetologia 12, 388 (1976)
  13. Ebert, R., Willms, B., Brown, J. C., Creutzfeldt, W.: Serum gastric inhibitory polypeptide (GIP) levels in obese subjects and after weight reduction. Eur. J. Clin. Invest. 6, 327 (1976)
  14. Ebert, R., Illmer, K., Creutzfeldt, W.: Abolishment of the incretin effect in rats by infusion of gastric inhibitory polypep- tide (GIP) antibodies. Seand. J. Gastroenterol. [Suppl. 49] 13, 53 (1978)

Cited by

Sorted by citations

Authors
Creutzfeldt, W.
Affiliations
Universitätsmedizin Göttingen (DE)
Corresponding author
Creutzfeldt, W.
Venue
Diabetologia
Published
1979-02
Volume
16
Issue
2
Pages
75-85
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2075404533
Cited by
731
References
68
Citations by year
2026: 6 · 2025: 9 · 2024: 19 · 2023: 13 · 2022: 16 · 2021: 14 · 2020: 6 · 2019: 21 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 24 · 2014: 17 · 2013: 22 · 2012: 14
FWCI
5.37
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
incretins, glucagon-like peptide-1, enteroinsular axis, gastrointestinal hormones, insulin secretion, insulin-induced hypoglycemia, hyperinsulinemia, obesity, duodenal ulcer, gastric acid secretion
MeSH terms
Absorption, Insulin Secretion, Diabetes Mellitus, Feedback, Gastrins, Gastrointestinal Hormones, Humans, Insulin, Obesity, Peptides, Vagus Nerve, Neurotransmitter Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review